✦ LIBER ✦

How Are Patient Populations Characterized in Studies Investigating Depression in Advanced Cancer? Results From a Systematic Literature Review

✍ Scribed by Janberidze, Elene; Hjermstad, Marianne Jensen; Haugen, Dagny Faksvåg; Sigurdardottir, Katrin Ruth; Løhre, Erik Torbjørn; Lie, Hanne Cathrine; Loge, Jon Håvard; Kaasa, Stein; Knudsen, Anne Kari

Book ID: 122017400
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 685 KB
Volume: 48
Category: Article
ISSN: 0885-3924
DOI: 10.1016/j.jpainsymman.2013.11.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How Are Palliative Care Cancer Populatio

How Are Palliative Care Cancer Populations Characterized in Randomized Controlled Trials? A Literature Review

✍ Sigurdardottir, Katrin Ruth; Oldervoll, Line; Hjermstad, Marianne Jensen; Kaasa, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Using mixed methods to assess how cancer

Using mixed methods to assess how cancer patients’ needs in relation to their relatives are met in the Danish health care system: a report from the population-based study “The Cancer Patient’s World”

✍ Lone Ross, Morten Aagaard Petersen, Anna Thit Johnsen, Louise Hyldborg Lundstrøm 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 211 KB

Endoscopic stenting for gastric outlet o

Endoscopic stenting for gastric outlet obstruction in patients with unresectable antro pyloric cancer. Systematic review of the literature and final results of a prospective study. The point of view of a surgical group

✍ Fiori, Enrico; Lamazza, Antonietta; DeMasi, Ercole; DeCesare, Alessandro; Schill 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

257 EFFICACY AND SAFETY OF TEVERELIX LA,

257 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE II MULTI-CENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL

✍ C. Maclean; F. Larsen; J. Drewe; A. Ulys; D. Kaniušas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 328 KB

EFFICACY AND SAFETY OF TEVERELIX, A NEW

EFFICACY AND SAFETY OF TEVERELIX, A NEW GONADOTROPHIN RELEASING HORMONE ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE 2 MULTICENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL INTRAMUSCULAR LOADING DOSE REGIMEN OF TEVERELIX

✍ C. Maclean; A. Ulys; F. Jankevičius; D. Kaniušas; J. Drewe; F. Larsen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

6570 POSTER Results for progression-free

6570 POSTER Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) are comparable when analysed by similar populations and methodology

✍ Sandler, A.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB